RNXT vs VNO · rev $266.0K vs rev $1.81B
RenovoRx Inc (RNXT) versus VNO (VNO) — a side-by-side from cached financials, not a winner call.
RenovoRx Inc (RNXT) is a biotechnology company listed on US.
VNO (VNO) common stock.
Latest reported RNXT revenue for 2025-09-30 was $266.0K. Net income was -$2.9M. Revenue was down 37.0% from 2025-06-30 to 2025-09-30. RNXT currently screens at market cap $47.0M.
Latest reported VNO revenue for 2025-12-31 was $1.81B. Net income was $905.0M. Revenue was up 1.3% from 2024-12-31 to 2025-12-31. VNO currently screens at market cap $0.
RNXT currently screens at market cap $47.0M. VNO currently screens at market cap $0.
Not investment advice. Open the RNXT and VNO stock pages for the full models.
Not investment advice.